Skip to main content
. 2022 Mar 3;16:1364. doi: 10.3332/ecancer.2022.1364

Table 4. Univariate and multivariate Cox regression analyses for outcomes in N+ adjuvant patients after matching (n = 66).

OS
Univariate Multivariate
Factor HR (95% CI) p HR (95% CI) p
Lymphovascular invasion
Absent 1
Present 2.139 (0.741–6.174) 0.160
T
T1 1
T2 2.461 (0.836–7.244) 0.102
T3 2.653 (0.332–20.935) 0.359
N
N1 1
N2 2.461 (0.836–7.244) 0.102
N3 2.635 (0.332–20.935) 0.359
Histological grade
G1/G2 1 1
G3 4.721 (1.534–14.523) 0.007 4.721 (1.534–14.523) 0.007
Molecular subtype
Luminal A 1
Luminal B 9.676 (1.236–75.773) 0.031
HER2 4.154 (0.375–46.002) 0.246
Triple-negative 10.333 (1.144–93.360) 0.038
DMFS
Lymphovascular invasion
Absent 1 1
Present 3.299 (1.196–9.102) 0.021 4.862 (1.649–14.335) 0.004
T
T1 1
T2 1.896 (0.553–6.498) 0.309
T3 Undefined 0.981
N
N1 1
N2 1.800 (0.647–5.010) 0.260
N3 1.494 (0.191–11.666) 0.702
Histological grade
G1/G2 1
G3 2.090 (0.670–6.525) 0.204
Molecular subtype
Luminal A 1 1
Luminal B 5.355 (1.169–24.533) 0.031 8.008 (1.675–38.294) 0.009
HER2 4.445 (0.813–24.313) 0.085 3.862 (0.704–21.203) 0.120
Triple-negative 5.770 (1.052–31.648) 0.044 8.572 (1.530–48.028) 0.015

G1 – well differentiated; G2 – moderately differentiated; G3 – poorly differentiated; N – lymph node metastasis